CAR-Ts Getting Boxed Warning On Secondary Malignancies Despite Sponsor Causation Questions

 
• By Derrick Gingery
  
CAR T cell and cancer
Sponsors have 30 days to submit updated labeling or a rebuttal explaining why the changes is not needed. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies